Mantle cell lymphoma differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
(Mahshid) |
||
Line 22: | Line 22: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Hematology]] | |||
[[Category:Immunology]] |
Revision as of 02:30, 27 November 2017
Mantle cell lymphoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Mantle cell lymphoma differential diagnosis On the Web |
American Roentgen Ray Society Images of Mantle cell lymphoma differential diagnosis |
Risk calculators and risk factors for Mantle cell lymphoma differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]
Overview
Mantle cell lymphoma must be differentiated from other diseases such as diffuse large B cell lymphoma, Mucosa-Associated Lymphatic Tissue lymphoma (MALT), small cell lymphocytic lymphoma, and follicular lymphoma.
Differential Diagnosis
Mantle cell lymphoma must be differentiated from other diseases such as:
- Diffuse large B cell lymphoma
- Mucosa-Associated Lymphatic Tissue lymphoma (MALT)
- Small cell lymphocytic lymphoma
- Follicular lymphoma